ES2100023T3 - Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios. - Google Patents

Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios.

Info

Publication number
ES2100023T3
ES2100023T3 ES94400082T ES94400082T ES2100023T3 ES 2100023 T3 ES2100023 T3 ES 2100023T3 ES 94400082 T ES94400082 T ES 94400082T ES 94400082 T ES94400082 T ES 94400082T ES 2100023 T3 ES2100023 T3 ES 2100023T3
Authority
ES
Spain
Prior art keywords
derivatives
preparation
application
cortisonic
intermediate products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400082T
Other languages
English (en)
Inventor
Jean Buendia
Remi Chauvin
Michel Vivat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2100023T3 publication Critical patent/ES2100023T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Epoxy Resins (AREA)

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS (I): R = OXO O (BETA) IBRE O PROTEGIDO, SU PREPARACION, SU APLICACION A LA PREPARACION DE COMPUESTOS (A): R3 ES UN AGRUPAMIENTO PROTECTOR DEL RADICAL HIDROXI, ASI COMO DE LOS INTERMEDIOS.
ES94400082T 1993-01-14 1994-01-13 Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios. Expired - Lifetime ES2100023T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300290A FR2700339B1 (fr) 1993-01-14 1993-01-14 Nouveaux dérivés 17,20-époxydes du pregnane, leur préparation, leur application à la préparation de dérivés cortisoniques et intermédiaires.

Publications (1)

Publication Number Publication Date
ES2100023T3 true ES2100023T3 (es) 1997-06-01

Family

ID=9443017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400082T Expired - Lifetime ES2100023T3 (es) 1993-01-14 1994-01-13 Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios.

Country Status (18)

Country Link
US (2) US5504203A (es)
EP (1) EP0607088B1 (es)
JP (1) JP3356525B2 (es)
KR (1) KR100312268B1 (es)
CN (2) CN1057304C (es)
AT (1) ATE151435T1 (es)
AU (1) AU667413B2 (es)
CA (1) CA2113404C (es)
DE (1) DE69402441T2 (es)
DK (1) DK0607088T3 (es)
ES (1) ES2100023T3 (es)
FR (1) FR2700339B1 (es)
GR (1) GR3023106T3 (es)
HU (1) HU217632B (es)
PL (1) PL181805B1 (es)
RU (1) RU2125060C1 (es)
UA (1) UA40574C2 (es)
YU (1) YU49025B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724174B1 (fr) * 1994-09-06 1997-01-17 Roussel Uclaf Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US9554418B1 (en) 2013-02-28 2017-01-24 F5 Networks, Inc. Device for topology hiding of a visited network
CN107663171A (zh) * 2017-10-10 2018-02-06 常州市阳光药业有限公司 高纯度托伐普坦的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2123217A (en) * 1937-07-15 1938-07-12 Merck & Co Inc Process for the production of hormones
US2541439A (en) * 1949-02-18 1951-02-13 Merck & Co Inc Osmate esters of 20-cyanopregnanes and process
US2648688A (en) * 1950-12-23 1953-08-11 Merck & Co Inc Process for peparing 21-alkyl ethers of cortisone
US2813860A (en) * 1954-12-31 1957-11-19 Upjohn Co Steroids
US2744108A (en) * 1955-01-13 1956-05-01 Searle & Co 3-ethylene mercaptoles of 11-oxygenated derivatives of 17, 21-dihydroxy-4-pregnene-3, 20-diones
US2912446A (en) * 1955-01-14 1959-11-10 Merck & Co Inc delta1, 4-3, 20-diketo-11-oxygenated-17alpha-hydroxy-pregnadienes and 9-fluoro derivatives thereof
US2844600A (en) * 1955-10-10 1958-07-22 Upjohn Co 22-cyanohydrins of bis-nor cholen-al compounds
US3285940A (en) * 1959-06-04 1966-11-15 Merck & Co Inc 16-methyl-delta-1, 4, 16-pregnatriene-3, 20-dione compounds
US3118882A (en) * 1961-02-16 1964-01-21 American Home Prod Preparation of 17alpha-fluoroprogesterone and intermediates therein
US3074979A (en) * 1961-05-08 1963-01-22 Merck & Co Inc 3-mono-oxime derivatives of c-4 unsaturated steroids
US3419550A (en) * 1965-08-23 1968-12-31 Warner Lambert Pharmaceutical Pentacyclic steroid intermediates and method of preparing the same
US3378574A (en) * 1966-03-30 1968-04-16 Merck & Co Inc Process of hydrolyzing 16beta-alkyl-16alpha, 17alpha-oxido-11, 20 bis-oxygenated-1, 4-pregnadiene-3, 20-diones
DE2330581A1 (de) * 1973-06-15 1975-01-16 Warner Lambert Co Steroidyloestratriene, ihre verwendung und verfahren zur herstellung derselben
DE2336438C2 (de) * 1973-07-14 1983-07-07 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 17 β- Oxalylsteroiden
HU171166B (hu) * 1975-07-15 1977-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh ehpoksi-androstanov
FR2423486A1 (fr) * 1978-04-19 1979-11-16 Roussel Uclaf Nouveau reactif d'epoxydation
US4600538A (en) * 1984-08-02 1986-07-15 The Upjohn Company Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes
FR2676740B1 (fr) * 1991-05-23 1993-11-05 Roussel Uclaf Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires.
FR2691968B1 (fr) * 1992-06-04 1994-07-29 Roussel Uclaf Nouveau procede de preparation d'un derive sterouide 11-ceto.

Also Published As

Publication number Publication date
HU217632B (hu) 2000-03-28
PL181805B1 (pl) 2001-09-28
HU9400094D0 (en) 1994-05-30
ATE151435T1 (de) 1997-04-15
US5504203A (en) 1996-04-02
FR2700339B1 (fr) 1995-03-03
YU82293A (sh) 1996-07-24
YU49025B (sh) 2003-07-07
CN1057304C (zh) 2000-10-11
US5892028A (en) 1999-04-06
KR100312268B1 (ko) 2002-06-20
CN1096790A (zh) 1994-12-28
FR2700339A1 (fr) 1994-07-13
GR3023106T3 (en) 1997-07-30
EP0607088A1 (fr) 1994-07-20
PL301862A1 (en) 1994-07-25
AU5316194A (en) 1994-07-21
EP0607088B1 (fr) 1997-04-09
JP3356525B2 (ja) 2002-12-16
CN1095847C (zh) 2002-12-11
UA40574C2 (uk) 2001-08-15
DE69402441T2 (de) 1997-10-30
CA2113404C (fr) 2004-10-19
RU2125060C1 (ru) 1999-01-20
CN1182092A (zh) 1998-05-20
AU667413B2 (en) 1996-03-21
DE69402441D1 (de) 1997-05-15
HUT67551A (en) 1995-04-28
KR940018395A (ko) 1994-08-16
JPH06279486A (ja) 1994-10-04
DK0607088T3 (da) 1997-10-06
CA2113404A1 (fr) 1994-07-15

Similar Documents

Publication Publication Date Title
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
ZA951227B (en) Camptothecin derivatives and process for their preparation
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2100023T3 (es) Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios.
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
HUT65943A (en) Process for producing benzothiazolylmethyl- and pyperazinomethyl-2,4,6-cycloheptatriene-1-one derivatives and pharmaceutical preparations containing them
DE59106966D1 (de) Verfahren zur Herstellung von 3-Amino-2-(het)aroyl-acrylsäurederivaten.
AU6893994A (en) Pharmaceutical compositions
TW427997B (en) New preparation process for a 16 β-methyl steroid and new intermediates
EP0395528A3 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
HU9701134D0 (en) New coumarin derivatives, processes for the preparation thereof and their use
ATE182335T1 (de) ''steroidzwischenprodukte und verfahren zu ihrer herstellung''
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
DE69229017D1 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
ES2071723T3 (es) Bencilseleniobenzoamidas de aminopiridinas y picolilaminas.
AU2148899A (en) 15-methyl-cyclopropanosteroids and method for the production thereof
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
FR2694002B1 (fr) Procédé de fabrication de 6E-leucotriène B4 et produits intermédiaires dudit procédé de fabrication.
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
DE69816095D1 (de) Herstellung von beta-mehtylcarbapenem-zwischenprodukten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 607088

Country of ref document: ES